• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病发病机制中线粒体质量控制途径的研究进展。

Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease.

机构信息

Department of Neurology and Neuroscience Center, First Hospital of Jilin University, Xinmin Street No. 71, Changchun 130000, China.

出版信息

Oxid Med Cell Longev. 2019 Aug 14;2019:4578462. doi: 10.1155/2019/4578462. eCollection 2019.

DOI:10.1155/2019/4578462
PMID:31485291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6710741/
Abstract

Parkinson's disease (PD), clinically characterized by motor and nonmotor symptoms, is a common progressive and multisystem neurodegenerative disorder, which is caused by both genetic and environmental risk factors. The main pathological features of PD are the loss of dopaminergic (DA) neurons and the accumulation of alpha-synuclein (-syn) in the residual DA neurons in the substantia nigra pars compacta (SNpc). In recent years, substantial progress has been made in discovering the genetic factors of PD. In particular, a total of 19 PD-causing genes have been unraveled, among which some members have been regarded to be related to mitochondrial dysfunction. Mitochondria are key regulators of cellular metabolic activity and are critical for many important cellular processes including energy metabolism and even cell death. Their normal function is basically maintained by the mitochondrial quality control (MQC) mechanism. Accordingly, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a kind of neurotoxin, exerts its neurotoxic effects at least partially by producing its toxic metabolite, namely, 1-methyl-4-phenylpyridine (MPP+), which in turn causes mitochondrial dysfunction by inhibiting complex I and mimicking the key features of PD pathogenesis. This review focused on three main aspects of the MQC signaling pathways, that is, mitochondrial biogenesis, mitochondrial dynamics, and mitochondrial autophagy; hence, it demonstrates in detail how genetic and environmental factors result in PD pathogenesis by interfering with MQC pathways, thereby hopefully contributing to the discovery of novel potential therapeutic targets for PD.

摘要

帕金森病(PD),临床上以运动和非运动症状为特征,是一种常见的进行性和多系统神经退行性疾病,由遗传和环境风险因素共同引起。PD 的主要病理特征是黑质致密部(SNpc)残留多巴胺能(DA)神经元中多巴胺能神经元的丧失和α-突触核蛋白(-syn)的积累。近年来,在发现 PD 的遗传因素方面取得了实质性进展。特别是,已经揭示了总共 19 个导致 PD 的基因,其中一些成员被认为与线粒体功能障碍有关。线粒体是细胞代谢活动的关键调节因子,对许多重要的细胞过程都至关重要,包括能量代谢甚至细胞死亡。它们的正常功能基本上由线粒体质量控制(MQC)机制维持。因此,神经毒素 1-甲基-4-苯基-1,2,3,6-四氢吡啶(MPTP)至少部分通过产生其毒性代谢物 1-甲基-4-苯基吡啶(MPP+)发挥其神经毒性作用,MPP+ 通过抑制复合物 I 并模拟 PD 发病机制的关键特征,进而导致线粒体功能障碍。本综述重点关注 MQC 信号通路的三个主要方面,即线粒体生物发生、线粒体动力学和线粒体自噬;因此,它详细说明了遗传和环境因素如何通过干扰 MQC 通路导致 PD 发病机制,从而有望为 PD 发现新的潜在治疗靶点做出贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d9/6710741/fb052da13c8d/OMCL2019-4578462.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d9/6710741/fb052da13c8d/OMCL2019-4578462.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5d9/6710741/fb052da13c8d/OMCL2019-4578462.001.jpg

相似文献

1
Current Progress of Mitochondrial Quality Control Pathways Underlying the Pathogenesis of Parkinson's Disease.帕金森病发病机制中线粒体质量控制途径的研究进展。
Oxid Med Cell Longev. 2019 Aug 14;2019:4578462. doi: 10.1155/2019/4578462. eCollection 2019.
2
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.重印本:重新探讨氧化应激和线粒体功能障碍在帕金森病发病机制中的作用——类似于安非他命类药物滥用的影响。
Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3.
3
IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.异柠檬酸脱氢酶2(IDH2)缺乏促进线粒体功能障碍和多巴胺能神经毒性:对帕金森病的影响
Free Radic Res. 2016 Aug;50(8):853-60. doi: 10.1080/10715762.2016.1185519. Epub 2016 May 24.
4
Modulation of mitochondrial phenotypes by endurance exercise contributes to neuroprotection against a MPTP-induced animal model of PD.耐力运动对线粒体表型的调节有助于对抗 MPTP 诱导的 PD 动物模型的神经保护。
Life Sci. 2018 Sep 15;209:455-465. doi: 10.1016/j.lfs.2018.08.045. Epub 2018 Aug 23.
5
Current perspective of mitochondrial biology in Parkinson's disease.帕金森病中线粒体生物学的当前观点。
Neurochem Int. 2018 Jul;117:91-113. doi: 10.1016/j.neuint.2018.03.001. Epub 2018 Mar 14.
6
Impaired mitochondrial dynamics and function in the pathogenesis of Parkinson's disease.线粒体动力学和功能受损在帕金森病发病机制中的作用
Exp Neurol. 2009 Aug;218(2):235-46. doi: 10.1016/j.expneurol.2009.03.006. Epub 2009 Mar 18.
7
Mitochondrial homeostasis regulation: A promising therapeutic target for Parkinson's disease.线粒体动态平衡的调控:帕金森病治疗的新靶点
Behav Brain Res. 2024 Feb 29;459:114811. doi: 10.1016/j.bbr.2023.114811. Epub 2023 Dec 14.
8
Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of parkinson's disease.泛醌(辅酶Q10)与帕金森病氧化应激中的线粒体
Biol Signals Recept. 2001 May-Aug;10(3-4):224-53. doi: 10.1159/000046889.
9
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness.帕金森病中新出现(和正在汇聚)的途径:维持线粒体健康
Biochem Biophys Res Commun. 2017 Feb 19;483(4):1020-1030. doi: 10.1016/j.bbrc.2016.08.153. Epub 2016 Aug 28.
10
Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.黑质中低水平的抑制素使帕金森病中的多巴胺能神经元易受损伤。
Mol Neurobiol. 2018 Jan;55(1):804-821. doi: 10.1007/s12035-016-0328-y. Epub 2017 Jan 6.

引用本文的文献

1
Alpha-Synuclein Effects on Mitochondrial Quality Control in Parkinson's Disease.α-突触核蛋白对帕金森病中线粒体质量控制的影响
Biomolecules. 2024 Dec 22;14(12):1649. doi: 10.3390/biom14121649.
2
Neuroprotective effects of GLP-1 class drugs in Parkinson's disease.胰高血糖素样肽-1类药物在帕金森病中的神经保护作用。
Front Neurol. 2024 Dec 10;15:1462240. doi: 10.3389/fneur.2024.1462240. eCollection 2024.
3
Electropositive Citric Acid-Polyethyleneimine Carbon Dots Carrying the PINK1 Gene Regulate ATP-Related Metabolic Dysfunction in APP/PS1-N2a Cells.

本文引用的文献

1
Evolving Concepts of Mitochondrial Dynamics.线粒体动态的演变概念。
Annu Rev Physiol. 2019 Feb 10;81:1-17. doi: 10.1146/annurev-physiol-020518-114358. Epub 2018 Sep 26.
2
Mechanisms of mitophagy in cellular homeostasis, physiology and pathology.细胞内稳态、生理学和病理学中的线粒体自噬机制。
Nat Cell Biol. 2018 Sep;20(9):1013-1022. doi: 10.1038/s41556-018-0176-2. Epub 2018 Aug 28.
3
Mechanisms Orchestrating Mitochondrial Dynamics for Energy Homeostasis.调控线粒体动态平衡的机制。
携带 PINK1 基因的正电性柠檬酸-聚乙烯亚胺碳点调节 APP/PS1-N2a 细胞中与 ATP 相关的代谢功能障碍。
Molecules. 2024 Apr 23;29(9):1907. doi: 10.3390/molecules29091907.
4
Early-Life Exposure to Paraquat Aggravates Sex-Specific and Progressive Abnormal Non-Motor Neurobehavior in Aged Mice.早年接触百草枯会加重老年小鼠特定性别的渐进性异常非运动神经行为。
Toxics. 2023 Oct 7;11(10):842. doi: 10.3390/toxics11100842.
5
Yap1-Usp14 Axis Inhibits Neuronal Mitophagy During Neonatal Hypoxia-Ischemia Encephalopathy by Regulation of Beclin-1 Ubiquitination in Mouse.Yap1-Usp14 轴通过调节 Beclin-1 泛素化抑制新生鼠缺氧缺血性脑病时的神经元自噬。
Mol Neurobiol. 2023 Aug;60(8):4273-4287. doi: 10.1007/s12035-023-03344-5. Epub 2023 Apr 17.
6
The multifaceted roles of natural products in mitochondrial dysfunction.天然产物在线粒体功能障碍中的多方面作用。
Front Pharmacol. 2023 Feb 13;14:1093038. doi: 10.3389/fphar.2023.1093038. eCollection 2023.
7
The deficiency of Maged1 attenuates Parkinson's disease progression in mice.Maged1 缺乏可减轻小鼠帕金森病的进展。
Mol Brain. 2023 Feb 11;16(1):22. doi: 10.1186/s13041-023-01011-3.
8
Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1α in a Mouse Model of Parkinson's Disease.利拉鲁肽通过 PGC-1α 调节帕金森病小鼠模型中的线粒体质量控制系统。
Neurotox Res. 2022 Feb;40(1):286-297. doi: 10.1007/s12640-021-00460-9. Epub 2022 Jan 18.
9
Black carrot anthocyanins exhibit neuroprotective effects against MPP+ induced cell death and cytotoxicity via inhibition of oxidative stress mediated apoptosis.黑胡萝卜花青素通过抑制氧化应激介导的细胞凋亡,对MPP+诱导的细胞死亡和细胞毒性具有神经保护作用。
Cytotechnology. 2021 Dec;73(6):827-840. doi: 10.1007/s10616-021-00500-4. Epub 2021 Oct 18.
10
Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders.氧化还原平衡与神经退行性疾病治疗靶点的展望。
Oxid Med Cell Longev. 2021 Aug 3;2021:9971885. doi: 10.1155/2021/9971885. eCollection 2021.
J Mol Biol. 2018 Oct 19;430(21):3922-3941. doi: 10.1016/j.jmb.2018.07.027. Epub 2018 Aug 5.
4
Mitochondrial dynamics in adaptive and maladaptive cellular stress responses.细胞应激反应中的适应性和失调性线粒体动态变化。
Nat Cell Biol. 2018 Jul;20(7):755-765. doi: 10.1038/s41556-018-0133-0. Epub 2018 Jun 27.
5
Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson's Disease and Huntington's Disease.神经退行性疾病中的线粒体质量控制:聚焦帕金森病和亨廷顿病
Front Neurosci. 2018 May 23;12:342. doi: 10.3389/fnins.2018.00342. eCollection 2018.
6
Cargo recognition and degradation by selective autophagy.选择性自噬对货物的识别和降解。
Nat Cell Biol. 2018 Mar;20(3):233-242. doi: 10.1038/s41556-018-0037-z. Epub 2018 Feb 23.
7
Mitochondrial Dynamics in Basal and Stressful Conditions.线粒体在基础和应激条件下的动态变化。
Int J Mol Sci. 2018 Feb 13;19(2):564. doi: 10.3390/ijms19020564.
8
Building and decoding ubiquitin chains for mitophagy.构建和解析用于线粒体自噬的泛素链。
Nat Rev Mol Cell Biol. 2018 Jan 23;19(2):93-108. doi: 10.1038/nrm.2017.129.
9
The genetics of Parkinson disease.帕金森病的遗传学。
Ageing Res Rev. 2018 Mar;42:72-85. doi: 10.1016/j.arr.2017.12.007. Epub 2017 Dec 26.
10
Mitophagy in Parkinson's Disease: Pathogenic and Therapeutic Implications.帕金森病中的线粒体自噬:致病及治疗意义
Front Neurol. 2017 Oct 4;8:527. doi: 10.3389/fneur.2017.00527. eCollection 2017.